Inter Pharma PCL
SET:IP

Watchlist Manager

Inter Pharma PCL

SET:IP

Watchlist

Dividends

Discount Rate

Price: 3.6 THB -1.1% Market Closed

Market Cap: 2.2B THB

Have any thoughts about
Inter Pharma PCL?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 3.6 THB

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

IP Alert

Inter Pharma PCL

3.6

-0.04 (-1.1%)

52 Week Range	3.3 6.7
Price Target

We'll email you a reminder when the closing price reaches THB.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Inter Pharma PCL

What unique competitive advantages
does Inter Pharma PCL hold over its rivals?

What risks and challenges
does Inter Pharma PCL face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Inter Pharma PCL.

What unique competitive advantages
does Inter Pharma PCL hold over its rivals?

What risks and challenges
does Inter Pharma PCL face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Inter Pharma PCL.

Provide P/S
for Inter Pharma PCL.

Provide P/E
for Inter Pharma PCL.

Provide P/OCF
for Inter Pharma PCL.

Provide P/FCFE
for Inter Pharma PCL.

Provide P/B
for Inter Pharma PCL.

Provide EV/S
for Inter Pharma PCL.

Provide EV/GP
for Inter Pharma PCL.

Provide EV/EBITDA
for Inter Pharma PCL.

Provide EV/EBIT
for Inter Pharma PCL.

Provide EV/OCF
for Inter Pharma PCL.

Provide EV/FCFF
for Inter Pharma PCL.

Provide EV/IC
for Inter Pharma PCL.

Show me price targets
for Inter Pharma PCL made by professional analysts.

What are the Revenue projections
for Inter Pharma PCL?

How accurate were the past Revenue estimates
for Inter Pharma PCL?

What are the Net Income projections
for Inter Pharma PCL?

How accurate were the past Net Income estimates
for Inter Pharma PCL?

What are the EPS projections
for Inter Pharma PCL?

How accurate were the past EPS estimates
for Inter Pharma PCL?

What are the EBIT projections
for Inter Pharma PCL?

How accurate were the past EBIT estimates
for Inter Pharma PCL?

Compare the revenue forecasts
for Inter Pharma PCL with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Inter Pharma PCL and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Inter Pharma PCL against its competitors.

Analyze the profit margins
(gross, operating, and net) of Inter Pharma PCL compared to its peers.

Compare the P/E ratios
of Inter Pharma PCL against its peers.

Discuss the investment returns and shareholder value creation
comparing Inter Pharma PCL with its peers.

Analyze the financial leverage
of Inter Pharma PCL compared to its main competitors.

Show all profitability ratios
for Inter Pharma PCL.

Provide ROE
for Inter Pharma PCL.

Provide ROA
for Inter Pharma PCL.

Provide ROIC
for Inter Pharma PCL.

Provide ROCE
for Inter Pharma PCL.

Provide Gross Margin
for Inter Pharma PCL.

Provide Operating Margin
for Inter Pharma PCL.

Provide Net Margin
for Inter Pharma PCL.

Provide FCF Margin
for Inter Pharma PCL.

Show all solvency ratios
for Inter Pharma PCL.

Provide D/E Ratio
for Inter Pharma PCL.

Provide D/A Ratio
for Inter Pharma PCL.

Provide Interest Coverage Ratio
for Inter Pharma PCL.

Provide Altman Z-Score Ratio
for Inter Pharma PCL.

Provide Quick Ratio
for Inter Pharma PCL.

Provide Current Ratio
for Inter Pharma PCL.

Provide Cash Ratio
for Inter Pharma PCL.

What is the historical Revenue growth
over the last 5 years for Inter Pharma PCL?

What is the historical Net Income growth
over the last 5 years for Inter Pharma PCL?

What is the current Free Cash Flow
of Inter Pharma PCL?

Discuss the annual earnings per share (EPS)
trend over the past five years for Inter Pharma PCL.

EV/EBITDA
Enterprise Value to EBITDA

12.1

Current

15.5

Median

10.3

Industry

Lower than median

Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA

12.1

Enterprise Value

2.1B THB

EBITDA

172.9m THB

All Countries

Forward Multiples

			Market Cap	EV/EBITDA
TH	I	Inter Pharma PCL SET:IP	2.2B THB	12.1
FR		L'Oreal SA PAR:OR	176B EUR	18.1
UK		Unilever PLC LSE:ULVR	117.3B GBP	177.7
IN		Hindustan Unilever Ltd NSE:HINDUNILVR	5.7T INR	38.2
UK		HALEON PLC LSE:HLN	34.7B GBP	17.1
DE		Beiersdorf AG XETRA:BEI	27.7B EUR	16
US		Estee Lauder Companies Inc NYSE:EL	25.1B USD	12.4
JP		Kao Corp TSE:4452	2.9T JPY	13.9
IN		Godrej Consumer Products Ltd NSE:GODREJCP	1.2T INR	39.1
IN		Dabur India Ltd NSE:DABUR	909.1B INR	38.5
US		Bellring Brands Inc NYSE:BRBR	10.2B USD	25.3

				EBITDA Growth
TH	I	Inter Pharma PCL SET:IP	Average EV/EBITDA: 37.1 12.1	N/A
FR		L'Oreal SA PAR:OR	18.1	28%
UK		Unilever PLC LSE:ULVR	177.7	20%
IN		Hindustan Unilever Ltd NSE:HINDUNILVR	38.2	29%
UK		HALEON PLC LSE:HLN	17.1	13%
DE		Beiersdorf AG XETRA:BEI	16	11%
US		Estee Lauder Companies Inc NYSE:EL	12.4	27%
JP		Kao Corp TSE:4452	13.9	55%
IN		Godrej Consumer Products Ltd NSE:GODREJCP	39.1	42%
IN		Dabur India Ltd NSE:DABUR	38.5	34%
US		Bellring Brands Inc NYSE:BRBR	25.3	43%

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBITDA

6.6

2-Years Forward

EV/EBITDA

N/A

3-Years Forward

EV/EBITDA

N/A

Inter Pharma PCL
SET:IP

EV/EBITDA
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Inter Pharma PCL SET:IP

EV/EBITDA Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Inter Pharma PCL
SET:IP

EV/EBITDA
Enterprise Value to EBITDA